Literature DB >> 15204375

Does brachytherapy of the prostate affect sperm quality and/or fertility in younger men?

Jack H Mydlo1, Brett Lebed.   

Abstract

OBJECTIVE: Sperm banking prior to surgical procedures which may affect fertility, such as retroperitoneal lymph node dissection, has been well documented. However, such procedures are usually performed in young men. With older men marrying later in life, or remarrying, we wanted to investigate the effects of radiation on prostate cancer patients who wanted to have children afterwards.
MATERIAL AND METHODS: We encountered several patients with prostate cancer who decided to undergo brachytherapy and were planning to have more children. We performed a search using PubMed and Ovid for the period 1966-2001 using the key words "fertility", "sperm banking", "radiation effects", "prostate cancer" and "brachytherapy".
RESULTS: Of the four young patients we encountered who underwent brachytherapy, we found no significant change in semen parameters post-therapy, and three of them were able to father a child subsequently without any deleterious side-effects. It has been demonstrated in several reports that external-beam radiation therapy is associated with decreased spermatogenesis due to Leydig cell dysfunction and decreased serum testosterone, as well as having a direct effect on spermatogonia. However, there is a scarcity of literature discussing the effects of prostate brachytherapy on spermatogenesis as the patients involved are usually older and usually do not desire to father any more children. As I has a half-life of 60 days, we used an exposure of 10 mR/h at the symphysis pubis and used integration to find the total dose exposed to the testis as follows: Limits 14 400 to 0, S 10e (-In2/1440.Tdt) where T = 14 400 and 20.75 R = 20.75 cGy. Therefore, the total dose was 20.75 cGy x 0.91 = 18.88 cGy. This value is considered too low to have any significant effect on testicular tissues.
CONCLUSIONS: We speculate that the effects of prostate brachytherapy on spermatogenesis in prostate cancer patients are minimal. However, due to the half-life of I, we recommend that these patients should wait for at least 3-4 months before trying to conceive. Furthermore, younger men with prostate cancer may want to consider sperm banking prior to brachytherapy if they want to have children in the future.

Entities:  

Mesh:

Year:  2004        PMID: 15204375     DOI: 10.1080/00365590410025451

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  6 in total

Review 1.  The efficacy of conventional external beam, three-dimensional conformal, intensity-modulated, particle beam radiation, and brachytherapy for localized prostate cancer.

Authors:  Tony Y Eng; Join Y Luh; Charles R Thomas
Journal:  Curr Urol Rep       Date:  2005-05       Impact factor: 3.092

2.  Sperm banking and the cancer patient.

Authors:  Daniel H Williams
Journal:  Ther Adv Urol       Date:  2010-02

Review 3.  Fertility preservation in the male with cancer.

Authors:  Daniel H Williams
Journal:  Curr Urol Rep       Date:  2013-08       Impact factor: 3.092

4.  Effects of gamma rays on rat testis tissue according to the morphological parameters and immunohistochemistry: radioprotective role of silymarin.

Authors:  Mohsen Marzban; Maryam Anjamshoa; Parnia Jafari; Hossien Masoumi; Reza Ahadi; Daryoush Fatehi
Journal:  Electron Physician       Date:  2017-06-25

Review 5.  Recovery of Spermatogenesis Following Cancer Treatment with Cytotoxic Chemotherapy and Radiotherapy.

Authors:  Keisuke Okada; Masato Fujisawa
Journal:  World J Mens Health       Date:  2018-11-27       Impact factor: 5.400

6.  Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression.

Authors:  Whoon Jong Kil; Romaine C Nichols; Bradford S Hoppe; Christopher G Morris; Robert B Marcus; William Mendenhall; Nancy P Mendenhall; Zuofeng Li; Joseph A Costa; Christopher R Williams; Randal H Henderson
Journal:  Acta Oncol       Date:  2013-04       Impact factor: 4.089

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.